NCT04484155View on ClinicalTrials.gov

Minimally Invasive Micro Sclerostomy: Safety and Preliminary Performance Study

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

March 2, 2020

Study Completion Date

March 5, 2020

Conditions
Glaucoma
Interventions
DEVICE

Minimally Invasive Micro Sclerostomy (MIMS)

The System is a surgical device, designed to create a drainage channel at the sclera-corneal junction . The drainage channel is created by a Stainless Steel surgical tool.

Trial Locations (1)

600086

Dr. Agarwal Eye Hospital Ltd., Chennai

All Listed Sponsors
lead

Sanoculis Ltd

INDUSTRY

NCT04484155 - Minimally Invasive Micro Sclerostomy: Safety and Preliminary Performance Study | Biotech Hunter | Biotech Hunter